Progressive Keratoconus
17
2
2
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
5.9%
1 terminated out of 17 trials
90.0%
+3.5% vs benchmark
35%
6 trials in Phase 3/4
33%
3 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (17)
Use of a Freeze-dried Amniotic Membrane Post Crosslinking in Subjects With Progressive Keratoconus
Corneal Crosslinking Treatment Study
Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus
Study to Evaluate the Safety and Efficacy of Epi-on Corneal Cross-linking in Eyes With Progressive Keratoconus
Corneal Collagen Cross-linking for Progressive Keratoconus
Efficacy and Safety ofCACXL in the Treatment of Keratoconus With Thin Corneas
Transepithelial Corneal Cross-linking Using Iontophoresis
Study of Demarcation Line Depth in Transepithelial Versus Epithelium-off Accelerated Cross-linking (AXL) in Keratocouns
Non-inferiority Trial of Iontophoretic Corneal Collagen Crosslinking (CXL) Compared to Standard Corneal Collagen Crosslinking in Progressive Keratoconus.
Corneal Crosslinking in Keratoconus and Corneal Ectasia
Stromal Demarcation Line: is it Predictive for Cross-Linking Efficiency?
Epi-keratoplasty Versus Collagen Cross-Linking in Progressive Keratoconus
Evaluation of Corneal Hysteresis and Corneal Resistance Factor After Corneal Cross-linking for Keratoconus
Corneal Thickness Changes During Corneal Collagen Cross-linking With Ultraviolet-A Irradiation and Riboflavin
Corneal Collagen Cross-Linking for the Treatment of Progressive Keratoconus and Corneal Ectasia
Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking for Compassionate Treatment in Pediatric Patients With Progressive Keratoconus
Safety and Effectiveness of Collagen Cross Linking in Progressive Mild and Moderate Keratoconus